Article
The biological role of metabolic reprogramming in pancreatic cancer
5 Nov 2020
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease and highly resistant to all forms of therapy. PDAC cells reprogram their metabolism extensively to promote their survival and growth. Reflecting the vital role of altered metabolism, experimental and clinical trials targeting the rewired metabolism are currently underway. In this review, we summarize the vital role of metabolic reprogramming in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
